Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
vectibix save search
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2023-10-22 (Crawled : 16:20) - prnewswire.com
CCXI | $51.99 -0.04%
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
| Email alert
Add to watchlist
BEIGF | $14.29 -9.87% 2.1K
|
n/a
| Email alert
Add to watchlist
lumakras cancer plus
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
Published: 2023-08-08 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: -3.96%
H: 0.0%
C: -5.41%
linzess sales year pharmaceuticals ironwood
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
Published: 2023-06-29 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.06%
H: 0.3%
C: -0.06%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: 0.09%
H: 1.7%
C: 0.76%
ironwood
Alentis Therapeutics Appoints Luca Santarelli as Chairperson
Published: 2023-06-29 (Crawled : 13:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.06%
H: 0.3%
C: -0.06%
therapeutics
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
Published: 2023-06-26 (Crawled : 20:00) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.12%
H: 0.41%
C: 0.41%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.47%
C: -0.56%
approved meeting
IMPORTANT ALERT: Halper Sadeh LLC Investigates VECT, SYNH, LSI, CHRA
Published: 2023-06-22 (Crawled : 17:00) - prnewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.12%
C: -0.24%
LSI | $133.1 -0.76% 0.0% 0
|
Finance
|
| O: 0.35%
H: 0.0%
C: -2.13%
EXR | $132.46 -1.3% 0.0% 1.5M
|
Finance
|
| O: 0.33%
H: 0.06%
C: -2.24%
SYNH | $42.98 0.0% 7.4M
|
Health Services
|
| O: -0.02%
H: 0.19%
C: 0.1%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: -0.28%
H: 1.94%
C: 1.85%
ALERT: The M&A Class Action Firm Continues Investigating the Merger - VECT, MYBF, CHRA, HMPT
Published: 2023-06-17 (Crawled : 08:20) - prnewswire.com
CHRA 4 | $6.16 -7.47% 100
|
Industrial Services
| Email alert
Add to watchlist
COOP 4 | $77.56 2.36% 2.31% 390K
|
Finance
| Email alert
Add to watchlist
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
HMPT | $2.32 0.0% 0
|
| Email alert
Add to watchlist
Moore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law Firm
Published: 2023-05-31 (Crawled : 17:00) - prnewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: -2.99%
H: 3.08%
C: -0.38%
EMBK | $2.88 0.35% 0.17% 0
|
Professional, Scientific, and T...
|
| O: -0.36%
H: 1.44%
C: 0.36%
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 0.31%
H: 0.98%
C: 0.91%
RADI | $15.0 0.0% 9.5M
|
Finance
|
| O: 0.14%
H: 0.27%
C: 0.0%
moore
Ironwood to Pay $1B to Acquire VectivBio, Late-Stage Digestive Therapy
Published: 2023-05-23 (Crawled : 05:00) - biospace.com/
ONON | $31.58 -4.33% -0.03% 3M
|
Manufacturing
|
| O: -0.58%
H: 1.9%
C: -2.53%
acquire ironwood therapy
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
Published: 2023-05-22 (Crawled : 12:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 42.13%
H: 1.79%
C: 0.31%
RY 1 d | $97.86 0.99% 0.0% 790K
|
Finance
|
| O: 0.23%
H: 0.0%
C: -0.28%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: -2.1%
H: 6.05%
C: 5.85%
rare biotech acquire ironwood gastrointestinal agreement
VectivBio Publishes Invitation to the Annual General Meeting - May 10, 2023
Published: 2023-05-10 (Crawled : 15:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.91%
H: 13.14%
C: 4.6%
meeting
VectivBio Publishes Invitation to the Annual General Meeting
Published: 2023-05-10 (Crawled : 13:00) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.91%
H: 13.14%
C: 4.6%
meeting
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
Published: 2023-04-19 (Crawled : 12:20) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 8.13%
H: 5.16%
C: 1.01%
business year update financial results
VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023
Published: 2023-04-12 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -2.9%
H: 0.57%
C: 0.0%
report business year update financial results
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
Published: 2023-03-13 (Crawled : 17:00) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.6%
H: 0.0%
C: -3.03%
pharma japan phase 1
VectivBio Announces Results of Extraordinary General Meeting-Wouter Joustra Elected to the Board of Directors
Published: 2022-12-09 (Crawled : 00:20) - biospace.com/
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: 7.83%
H: 0.0%
C: -2.49%
results
VectivBio Publishes Invitation to the Extraordinary General Meeting of Shareholders
Published: 2022-11-16 (Crawled : 13:20) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
meeting
VectivBio to Present at the 2022 Jefferies London Healthcare Conference
Published: 2022-11-09 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 2.64%
H: 2.97%
C: 1.72%
conference
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
Published: 2022-10-18 (Crawled : 14:00) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -3.86%
H: 8.9%
C: 5.6%
offering
VectivBio Reports Positive Interim Clinical Data from STARS Nutrition, a Phase 2 Study Investigating Apraglutide in Short Bowel Syndrome with Intestinal Failure Patients (SBS-IF) with Colon-In-Continuity (CIC)
Published: 2022-10-13 (Crawled : 13:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 27.84%
H: 0.0%
C: 0.0%
positive study
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.